is an approximate formula for the exact beta-Poisson model. Notwithstanding the required conditions ≪ and ≫ 1, issues related to the validity and approximation accuracy of this approximate formula have remained largely ignored in practice, partly because these conditions are too general to provide clear guidance. Consequently, this study proposes a probability measure Pr(0 < < 1| �, ̂) as a validity measure ( is a random variable that follows a gamma distribution; � and ̂ are the maximum likelihood estimates of and in the approximate model); and the constraint conditions ̂> (22 �) 0.50 for 0.02 < � < 2 as a rule-of-thumb to ensure an accurate approximation (e.g., Pr(0 < < 1| �, ̂) > 0.99) . This validity measure and rule-ofthumb were validated by application to all the completed beta-Poisson models (related to 85 datasets) from the QMRA community portal (QMRA Wiki). The results showed that the higher the probability Pr(0 < < 1| �, ̂) , the better the approximation. The results further showed that, among the total 85 models examined, 68 models were identified as valid approximate model applications which all had a near perfect match to the corresponding exact beta-Poisson model dose-response curve.
Abstract: For dose-response analysis in Quantitative Microbial Risk Assessment (QMRA), the exact beta-Poisson model is a two-parameter mechanistic dose-response model with parameters > 0 and > 0, which involves the Kummer confluent hypergeometric function. Evaluation of a hypergeometric function is a computational challenge. Denoting ( ) as the probability of infection at a given mean dose , the widely used dose-response model ( ) = 1 − �1 + �
INTRODUCTION
Quantitative Microbial Risk Assessment (QMRA) (1, 2) is a valuable framework for analysing the adverse health outcomes associated with exposures to pathogenic organisms. (3, 4) The QMRA approach is a fourstep process comprising (i) hazard identification; (ii) exposure assessment; (iii) dose-response analysis;
and (iv) risk characterization. (1, 2) QMRA has become increasingly accepted by health authorities and is referenced in many major health guideline documents pertaining to water-borne pathogens (e.g., drinking
water, (5, 6) wastewater irrigation, (7) (8) (9) recreational waters, (10) ) and to food-safety. (6, 11) QMRA has also been used widely by researchers to characterize microbial risks associated with food, water, and wastewater use in agriculture. (1, 3, 12) The core part of the QMRA framework is the dose-response analysis which models the mathematical characterization of the relationship between the dose administered and the probability of adverse effect (typically, the probability of infection) in the exposed population. (1, 2) Among different microbial dose-response models proposed in the QMRA literature, the beta-Poisson model remains as the most popular plausible dose response model. (1, 2, 6) The beta-Poisson dose-response model and its special case, the exponential dose-response model, have been well studied and widely employed to characterize infectivity of various viral, bacterial, and protozoan pathogens since the 1980s. (1, 2, 6, 13, 14) Due to the mathematical complexity in its model specification and the difficulty in parameter estimation in the exact beta-Poisson model (model specification details are presented in Section 2.2), an approximate version of the beta-Poisson model is commonly used in QMRA dose-response analysis. (1, 2, 13, 15) This approximate beta-Poisson model is specified as
where represents the known mean dose; > 0 and > 0 are the model parameters to be estimated. (1, 15, 16) It is well known that the valid application of Equation (1) is subject to the general rule: ≪ and ≫ 1, (1, 15, 16) but no commonly agreed, specific rules are available in the QMRA literature for researchers and practitioners to apply for the assessment of the validity or the approximation performance of the approximate beta-Poisson model (Equation (1)). Two things make these assessment conditions difficult to apply: (1) the true parameters, and are unknown; (2) the general rule conditions are not specific enough to apply. As a consequence, the validity and approximation accuracy issue in the application of the approximate model has remained largely ignored. This study aims to address this issue.
Based on theoretical justification, a gamma distribution probability measure is proposed as a validity measure upon which a rule-of-thumb is specified to ensure an accurate approximation in the applications of the approximate beta-Poisson dose-response model. Importantly, the rule-of-thumb uses the maximum likelihood estimates (MLEs) of and ( � and ̂) obtained from the approximate model (i.e.,
Equation (1)). Therefore, this study provides revised guidelines which are practical to apply for the assessment of a valid use of the approximate beta-Poisson model.
The QMRA Wiki (2) is a community portal for current quantitative information and knowledge developed for the quantitative microbial risk assessment field. This study has taken the advantage of having the free access to the possibly most complete collection of the experimental dose-response datasets reported in the literature as now available from the QMRA Wiki (2) . The proposed rule-of-thumb is applied to all the completed beta-Poisson models (related to 85 datasets) presented in the QMRA Wiki (2) for validation.
The rule-of-thumb is validated through matching the dose-response curves between the approximate models and the corresponding exact models, and by taking into account the uncertainty in parameter estimation. The research results from this study are expected to provide a better understanding and facilitate the future applications of the beta-Poisson models in QMRA practice.
The rest of the paper is organized as follows. Section 2 provides a description of the theoretical background (model specifications and the parameter estimation procedure), and the data and notation used throughout the study. Section 3 provides the theoretical and empirical justification for developing the rule-of-thumb and describes the validation procedure for this rule-of-thumb. The validation results are then presented and discussed in Section 4, illustrating how the rule-of-thumb is validated through matching the dose-response curves and demonstrates how uncertainty is taken into account in this validation process using confidence bands. Section 5 presents the conclusions drawn from the research.
NOTATION, THEORETICAL BACKGROUND, AND DATA

Notation And Definitions
For the purpose of a clear and consistent model specification and easy comparison with the literature results, we have adopted a notation scheme as detailed in Table I throughout this paper. The term 'organism' is used as a short name for pathogenic microorganism. 
Γ(•)
the gamma function (17) 
Model Specification
The detailed description and derivation of the exponential and the beta-Poisson dose-response models can be found in the QMRA literature, e.g., Haas et al (2014) (1) . For the purpose of this paper, the following model specifications are needed.
Based on the assumptions that (i) the actual number of organisms ingested by a host subject (e.g., a human or an animal) is a random variable which follows a Poisson distribution with parameter (the known mean dose, i.e., the dose is assumed to have Poisson error (15, 18) ); (ii) one organism is capable of initiating an infection if it arrives at an appropriate site within a host subject; (iii) organisms have independent and identical probability ( ) of surviving to reach and initiate an infection at an appropriate site, the simplest QMRA dose-response model (the exponential model) can be derived as: (1, 18) ( ) = 1 − exp(− ) .
In Equation (2), if we take into account the host susceptibility or host sensitivity by allowing to follow a beta distribution with the probability density function (pdf):
where 0 < < 1, and parameters > 0 and > 0, we obtain the well-known exact beta-Poisson doseresponse model: (1) ( ) = 1 − ( , + , − ) ( , + , − )
Since there are no analytic solutions to ( , + , − ) 1 1 , only approximate solutions or asymptotic solutions can be obtained (19, 20) . In their original paper, Furumoto and Mickey (16) derived the attractive approximation beta-Poisson dose-response formula:
The approximate formula (Equation (1)) provided a simple solution for those using QMRA to circumvent the computational difficulties caused by the inherent mathematical complexity of the exact beta-Poisson dose-response model (Equation (4)). By series expansion, Furumoto and Mickey (1967) (16) showed that, given a fixed value of , for sufficiently large values of , Equation (1) is a valid approximation for Equation (4); they also asked readers to pay attention to the cases when < 1 and > 1, and a particular example with = 0.0001 and = 4.0 was given to show a good approximation of Equation (1) for Equation (4) . Many years later, Teunis and Havelaar (2000) (15) noted that Equation (1) can be derived from a different perspective. By starting again from the exponential model (Equation (2)), let variable follow a gamma distribution with the pdf:
where > 0, and > 0 and > 0 are the parameters. It is a routine integration exercise to derive Equation (1) as an exact gamma-Poisson model specification. (15) The conditions ≪ and ≫ 1 were then explicitly specified by Teunis and Havelaar (2000) for a valid use of Equation (1) Poisson models, given the parameter estimates � and ̂. This is the theoretical ground for the development of the rule-of-thumb for a valid use of Equation (1) and details are given in Section 3.1.
Parameter Estimation
In this paper, the same optimization summary statistic for parameter estimation is used for both the approximate and the exact beta-Poisson models. This is defined as
Note that Equation (7) is a reproduction of Equation 8.33 in Haas et al. (p285 (1) ). In Equation (7), is the number of exposure groups in terms of the mean dose level ; is the total number of individuals in the th exposure group (total groups); is the number of infected subjects in the th exposure group; is the predicted probability of infection of the th exposure group; and = / is the ratio of the observed number of infected subjects to the number of all subjects at risk at each mean dose level (see Table I for the notation and definition details). The summary statistic defined by Equation (7) is a measure of the discrepancy between the observed responses ( ) and the model predicted responses ( ) of the dose-response data. (23) Note that if estimating = ( ) from Equation (1) and then substituting the results into Equation (7), the maximum likelihood estimates (MLEs) of the model parameters, � and ̂, are obtained for the approximate beta-Poisson model by minimizing (1, 24) ; if, instead, estimating = ( ) from Equation (4) and then substituting the results into Equation (7), � and ̂, the MLEs of the model parameters of the exact beta-Poisson model will be obtained.
The evaluation of the Kummer confluent hypergeometric function (Equation (5)) is non-trivial but can be obtained by using the R (25) function 'hyperg_1F1' in the R package 'gsl'. (26) The built-in optimization function 'optim' in R is employed to obtain the MLEs of and that minimize for both the approximate and the exact beta-Poisson models 2 .
Datasets
The QMRA Wiki (2) presents 138 feeding trial experimental dose-response datasets and each of them was fitted either by an exponential dose-response model ( Equation (2)) or by an approximate beta-Poisson dose-response model (Equation (1)). Of these 138 datasets, 53 are best fitted by the exponential model and 85 are best fitted by the approximate beta-Poisson model as presented in the QMRA Wiki (2) . The exact beta-Poisson model (Equation (4)) was not used for fitting the dose-response data in the QMRA Wiki (2) . It is these 85 datasets used for fitting the approximate beta-Poisson dose-response model in the QMRA Wiki (2) are examined in this study for validating the proposed rule-of-thumb. Due to the space limitation, only the descriptions for each of these 85 datasets are provided in this paper ( Table III in the appendix). Readers are reminded that the data analysis results produced from this study are based on the data details presented in the QMRA Wiki (2) . For the originality and the correctness of these datasets readers should refer to the original references provided in the QMRA Wiki (2) .
A RULE-OF-THUMB FOR THE APPROXIMATE BETA-POISSON MODEL
Development Of The Rule-of-thumb
The theoretical ground for the development of the rule-of-thumb for a valid use of the approximate beta-Poisson model (Equation (1)) lies in the fact that Equation (1) can be derived as the exact gamma-Poisson model in which the random variable , being assumed as a probability in the dose-response analysis (as defined in Table I ), follows a gamma distribution which cannot guarantee 0 < ≤ 1. Therefore, to ensure a valid application of Equation (1) as a dose-response model, the model parameters α and β should be confined to an admissible range/area such that Pr(0 < r <1) is very close to one; for example, this may be arbitrarily defined as Pr(0 < r < 1) > 0.99. This probability measure, Pr(0 < r < 1), is defined as:
where ( | , ) is the gamma distribution pdf defined by Equation (6). Equation (8) can be evaluated easily using a standard statistical software program (e.g., the built-in R (25) function 'pgamma'). For example, Pr(0 < < 1| = 1, = 4.63) is 0.9902 (up to 4 decimal places (dp) accuracy).
In QMRA practice, the model parameters and are unknown and the MLEs are accepted as the valid estimates of and for the estimation of the probability Pr(0 < r < 1| , ) in Equation (8). Since the purpose of developing this rule-of-thumb is for facilitating the evaluation of Equation (4), it is the MLEs obtained from Equation (1), � and ̂, will be used so that Equation (8) The relationships between the probability Pr(0 < < 1) and model parameters and are examined in Fig. 1(a) , the Pr(0 < < 1) = 0.99 contour line starts from the origin and increases monotonically and smoothly along the horizontal axis (i.e., is positively correlated with in terms of the probability contour lines). The increase appears very linear for 2 ≤ < 20 in Fig. 1(a) . It is therefore likely that the contour line can be best approximated using a piece-wisely fitted curve, e.g., by a power function (or power laws (27) ) of the form the condition > (22 ) 0.50 could be considered as a sufficient and necessary condition to ensure Pr(0 < < 1| , ) > 0.99 (2 dp) for 0.02 < < 2. By taking into account both the theoretical justification and the QMRA data analysis empirical evidence, a rule-of-thumb for a valid use of Equation (1) is therefore specified as:
i.
obtain the parameter estimates � and � from Equation (1); ii. if and only if the resulting parameter estimates satisfy the condition ̂> (22 �) 0.50 for 0.02 < � < 2, Equation (1) is considered a valid application as an accurate approximation to Equation Table   II in Section 4.1.
For � ≤ 0.02 or � ≥ 2 cases, if future QMRA practice does show a demand for the guidelines to better cover these cases, the proposed rule-of-thumb can always be revised following the methodology described in this section with or without any new dose-response data analysis evidences. For example, it has been shown in Fig. 1(a It is worth noting that, by following the same development approach described above, one could specify a different rule-of-thumb based on a criterion of one's choice, e.g., Pr(0< <1| �,̂) > 0.95 or Pr(0< <1| �,̂) > 0.999 for the purpose of approximation performance assessment.
This rule-of-thumb is supposed to ensure an accurate approximation in terms of matching the doseresponse curves produced by Equation (1) and Equation (4). However, if the approximation performance is assessed by taking into account the uncertainty in the model parameter estimation, other factors are involved, such as the number of the data points and how the mean dose range has been covered by these data points. Therefore, the performance of the rule-of-thumb by matching the confidence bands about the dose-response curves should also be assessed. For a better understanding and interpretation of the validation results, the procedure/methodology of how to validate this rule-of-thumb using empirical dose response datasets is described next in subsection 3.2 before the presentation and discussions of the validation results in Section 4.
Validation Methodology For The Rule-of-thumb
The rule-of-thumb should be validated by application to as many as possible of the completed beta-Poisson models related to experimental dose-response data in QMRA practice (e.g., those datasets listed in Table III ). The first step in the validation process is to fit both the approximate and the exact beta-Poisson models to each of the 85 datasets by following the parameter estimation procedure described in (1) is then assessed by drawing and superposing the dose-response curves of
Equations (1) and (4) for those datasets which have been identified as sensitive to the sampling variation, the confidence bands of the dose-response curves are plotted and superposed by the data points (the fractions of the infected subjects) to examine the impact of the uncertainty in parameter estimation. As it is well accepted in QMRA practice, a parametric bootstrap algorithm (29) is employed to construct the 95% confidence bands for the dose-response curves. (1, 2, 13, 15) The validation analysis on the rule-of-thumb is conducted by following the process as described above and the validation results and the discussions are presented in the next section.
VALIDATION RESULTS AND DISCUSSION
The validation process described in Section 3.2 is followed for validating the rule-of-thumb with respect to all 85 datasets listed in Table III . The performance of the rule-of-thumb is first examined by matching the corresponding dose-response curves produced from Equation (1) and Equation (4) and these validation results are presented in Section 4.1. Since a good match in dose-response curves does not guarantee a good match for the confidence bands if the ̂ value in the model is not large enough (e.g., ̂ < 100), (15, 22) those valid approximate beta-Poisson models with datasets which are sensitive to the sampling variations are then identified and examined for the impact of the uncertainty in parameter estimation as presented in Section 4.2.
Validation Of The Rule-of-thumb By Matching The Dose-Response Curves
The numeric outputs of the validation results are summarised in Correspondingly, it shows that the Pr(0< <1| �,̂) values for models 1 to 17 are much lower than those Pr(0< <1| �,̂) values obtained from models 18 to 85 which are identified as valid application cases.
All 17 invalid models have a Pr(0< <1| �,̂) value less than 0.99. Of the 68 valid models (related to datasets 18 to 85), 65 models have the probability Pr(0< <1| �,̂) > 0.9999, and the model related to dataset 42 has a probability Pr(0< <1| �,̂) = 0.9990 (4 dp); the model related to dataset 72 has a probability Pr(0< <1| �,̂) = 0.9996 (4 dp), and the model related to dataset 78 has a probability Pr(0< <1| �,̂) = 0.9971 (4 dp).
Based on the numeric validation results presented in Table II , one is able to draw dose-response curves to examine any visually identifiable discrepancies between the approximate model and the exact model.
The dose-response curves matching results for models 1 to 17 (i.e., all invalid approximate models) are displayed in Fig. 2 and the dose-response curves matching results for models 18 to 85 (i.e., all valid approximate models) are displayed in Fig. 3 . Therefore, if there are two colours or two curves visually identifiable in a plot, it is considered as a definite evidence of an unacceptable approximation case. For models related to datasets 1 to 17 (the 17 invalid models) displayed in Fig. 2 , the majority of the plots (e.g., 13 models related to datasets 1, 2, 4 through to 13, and 17) have showed substantial discrepancy patterns. By looking at the numeric results in column 7 of Table II , it shows that Pr(0 < < 1| �, ̂) < 0.92 for these 13 models. In contrast, for models related to datasets 18 through to 85 displayed in Fig.3 (the 68 valid models 
is derived from Equation (1). Therefore, this formula (Equation (9)) is only applicable for calculating N50 in the approximate beta-Poisson model cases. It could be very misleading if one applies Equation (9) using the exact model parameter estimates. For example, for dataset 11 (rotavirus experiment 70 data, (Table II ) and a visually identifiable deviation is found in the dose-response curves (Fig. 2) . By applying Equation (9) As noted in Teunis and Havelaar (2000) (15) and Schmidt et al. (2013) (22) , a near perfect match in doseresponse curves does not guarantee a good match in confidence bands (i.e., when uncertainty in model parameters is taken into account). Importantly, those valid models with ̂ values less than 100 are likely to have a poor confidence band. Not surprisingly, those a handful valid models which have showed some subtle discrepancy signs in dose-response curves, i.e., models related to datasets 21, 25, 30, 42, 69, 71, and 78, all fall into this category, i.e., their ̂ values are all less than 100 (column 3, Table II ). The impacts of the uncertainty in parameter estimation for these models are examined next in Section 4.2. Fig. 3 . Validation of the rule-of-thumb by matching the dose-response curves produced by the approximate and exact beta-Poisson models based on parameter estimates presented in Table II: (0.001) to 10 11 (100,000,000,000).
Validation Of The Rule-of-thumb By Taking Into Account Uncertainty
Among the 68 valid approximate beta-Poisson models (related to datasets 18 through to 85), nine models are selected for validation of the rule-of-thumb by taking into account the uncertainty in parameter estimation and the outcomes are graphically shown in Fig. 4 . These 10 datasets are cited from the QMRA Wiki (2) and the details are provided in Table IV in the appendix.
In Fig. 4 , the bold red dashed lines represent the maximum risk dose-response curve. This is a limiting case for beta-Poisson dose-response models where the curve obtained from the exact model (Equation 4) can never go beyond this maximum risk dose-response curve, even when parameter uncertainty is taken into account. (15) This allows the performance of the approximate model (Equation 1) to be examined by identifying any cases where the 95% confidence bands of the exact and the approximate models do not match or where the upper bound curves of the approximate models go beyond the maximum risk doseresponse curves. In cases where these maximum risk dose-response curves are exceeded, it is implied that the approximate model is predicting more illnesses than actual exposures (i.e., the probability of infection exceeds the probability of ingesting any organisms). lines. The bold red dashed lines represent the maximum risk dose-response curve. The horizontal axis measures the mean dose (on the natural log scale) ranged from 10 -3 (0.001) to 10 11 (100,000,000,000).
By examining every plot in Fig. 4 , the most obvious feature is that, with no exceptions, the dose-response curves are very closely aligned (i.e., the red solid lines for the approximate models are almost completely superimposed by the bold black solid lines) as we expect, despite the different deviation patterns in the confidence bands. (Table II) .
From these plots it is a surprise to notice that the dataset 30 model behaves much poorly than dataset 67 model in that the upper bound curves of the confidence band deviate badly between the approximate and the exact models for dataset 30 while it is almost a perfect match for dataset 67. We attribute the primary reason for the poor performance by dataset 30 model to the fact that its mean dose level coverage range is extremely biased towards the higher end of the horizontal axis (e.g., no data points for < 10 8 , Table IV ).
In contrast, the near perfect match in confidence bands for dataset 67 model is due to its good coverage of the mean dose levels across the horizontal axis range. A similar conclusion may be drawn if we apply this logical reasoning to examine plots related to datasets 23, 70, 73, and 78. Each of these four datasets contains four or six data points. Those datasets with better coverage of the mean dose levels have better matching of the confidence bands (e.g., dataset 70).
By examining the deviation pattern displayed in the plot related to dataset 54 (a dataset with 24 data points, Table IV ), a different influence factor is identified. It is noted that most of the data points in dataset 54 has a very small number of participated subjects in the exposure groups, e.g., = 2. This implies that the observed response = / can only be one of the three possible outcomes: {0/2, 1/2, 2/2}, while theoretically should allow to take any value between zero and one. This = 2 effect is clearly shown in the plot related to dataset 54 in Fig. 4 -all data points, except two, fall on the horizontal ( ) = 1 line. As a consequence, the upper bond curve of the dataset 54 model's confidence band not only deviates from the exact model badly also go far beyond the maximum risk dose-response curve. In contrast, those models with data points well spread over the vertical axis have shown a much better pattern in matching the confidence band. For datasets 21, 42, and 55, the confidence band deviation or the violation of the maximum risk dose-response boundary also occur but to a lesser extent.
The above analysis results have the implications for us to make the following suggestion (with regard to a valid application of Equation (1) by taking into account the uncertainty): the quality of the dose-response data should not be ignored in assessing the validity of Equation (1) for dose-response analysis. Very biased data coverage, either on horizontal axis (the mean dose level coverage) or on vertical axis (the observed infected subject fractions coverage) will cause severe information loss (or is an indication for lack of information), hence unreliable confidence bands outside the data range are expected for both the approximate and the exact model. Therefore, as long as it is explicitly stated that the 95% confidence band is constructed based on Equation (1), use it anyway for QMRA because the approximation remains reasonably good within the data coverage range as shown in Fig. 4 and neither confidence bands are the reliable estimates of the true risk upper limit outside the data range. Over the mean dose range where the upper bound curve of the approximate model confidence band goes beyond the possible risk limit, the maximum risk dose-response curve should be used instead as the upper bound.
CONCLUSIONS
It is not unusual that researchers or practitioners are deterred from using the exact beta-Poisson doseresponse model in QMRA practice. This is due to the mathematical complexity in its model specification and the difficulty in parameter estimation (e.g., when conducting QMRA using the Microsoft Excel as an The validation results showed that the proposed rule-of-thumb ensured a near perfect match in doseresponse curves between the approximate and the exact models for all the 68 cases which were identified as valid applications (i.e., the rule-of-thumb condition was satisfied). By taking parameter estimation uncertainty into account, the validation results further indicated that, given a good match in the doseresponse curve, any substantial deviations in the 95% bootstrap confidence bands signified a need for better dose-response data to ensure a reliable QMRA outcome. Of the 85 beta-Poisson models examined here, there were 17 cases of invalid application of the approximate model identified by the rule-of-thumb.
The majority of these invalid cases (13 out of 17) showed clear (i.e., visually identifiable) discrepancies in matching the dose-response curves and, therefore, they represented cases where the exact beta-Poisson model should have been applied. For the four remaining invalid cases (in which the approximation performances were much better than the above mentioned 13 cases), it was recommended that researchers should use their discretion to decide if the approximate model should be considered as a valid application on an ad hoc basis. The research findings reported in this paper provide improved guidance that will ensure the valid application of the approximate beta-Poisson formula. In turn, use of the proposed ruleof-thumb should instil more confidence in the applications of the approximate beta-Poisson dose-response model in microbial health risk assessment practice.
29. Efron B, Tibshirani RJ. An introduction to the bootstrap: CRC press; 1993. 
APPENDIX: DATASETS AND CURVE FITTING DETAILS
Number of infections (y)
1 1 3 4 * Readers are reminded that for the originality and the correctness of these datasets please refer to the original references provided therein QMRA Wiki (2) .
Curve fitting details
For approximation of the Pr(0 < < 1| , ) = 0.99 probability contour line through curve fitting, the best-fit power function curve ( < 2) and the best-fit straight line (2 ≤ < 20) are obtained using the least-squares estimation method (27) implemented with R function 'optim' (27) . The fitted power function is in the form of = (A ) B and the linear (i.e., straight line) function is in the form of = A + B where A and B are parameters to be estimated. It is a two-step process to obtain the parameter estimates.
Step 1 is to obtain the paired and values in which values are first arbitrarily determined over the range [0.001, 20] as shown in Table V and then the corresponding values are determined by trial and error using the built-in R function 'pgamma' (27) such that pgamma(1, , ) ≥ 0.99. The paired and values obtained in such a way accurately characterize the 0.99 probability contour line; Step 2 is to use R function 'optim' to find the best-fit least-squares estimates for A and B by matching the paired and values obtained in Step 1, i.e., given the same values, the optimal parameter estimates A and B minimise the differences between the values in Table V and 
